comparemela.com

Latest Breaking News On - Atrial fibrillation patients - Page 1 : comparemela.com

Daiichi Sankyo Europe GmbH: Four-year follow-up data reinforces the consistent effectiveness and safety of treatment with edoxaban in patients with atrial fibrillation (AF)

Daiichi Sankyo Europe GmbH: Four-year follow-up data reinforces the consistent effectiveness and safety of treatment with edoxaban in patients with atrial fibrillation (AF)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Acutus Medical Completes Enrollment in IDE Trial with its AcQBlate FORCE Sensing Ablation System

Acutus Medical Completes Enrollment in IDE Trial with its AcQBlate FORCE Sensing Ablation System
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

FDA Expands Arctic Front Family of Cryoablation Catheters for Initial Use in Recurrent Symptomatic Paroxysmal AF

FDA Expands Arctic Front Family of Cryoablation Catheters for Initial Use in Recurrent Symptomatic Paroxysmal AF
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Huma raises $130 million financing to scale its digital health platform for better care and research

LONDON and NEW YORK  , May 12, 2021 /PRNewswire/  Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately $130 million. The investment will scale Huma s modular platform which can power digital hospitals at home nationally, and support the pharmaceutical and research industries to run the largest ever decentralized clinical trials. Huma s platform combines predictive algorithms, digital biomarkers and real-world data to advance proactive care and research. Leaps by Bayer and Hitachi Ventures led the Series C funding round, which also saw new strategic and financial investors become shareholders. Samsung Next, Sony Innovation Fund by IGV , Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (former president of SoftBank) and Michael Diekmann (Chairman of Allianz) are also new shareholders.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.